Clinical Trial Update: The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tacrolimus with high-dose dexamethasone as first-line therapy for adult immune thrombocytopenia; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia
• Itp

Drugs mentioned

• Dexamethasone (high-dose) (dexamethasone)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Peking University People's Hospital | Conditions: ITP, Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN